Absci Corporation

ABSI· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$9.69-12.98%

2026-11-02

Financials

Valuation Metrics

Absci Corporation's Market Cap is $1.66B. At end of 2025 it was $502M. Ranked #2003 of 3,118 in US market (top 64%), #751 of 1,474 on NASDAQ (top 51%), #140 of 265 in Pharmaceuticals, Biotechnology & Life Sciences (top 53%) by Market Cap.

Investment Metrics(as of 2026-11-02)

Metric	Value	Rank
Size
Market Cap	$1.66B	US#2,003/3,118 Sec#140/265
Revenue	$2M	US#2,841/3,118 Sec#187/265
Net Income	$-121M	US—/3,118 Sec—/265
Total Assets	$269M	US#2,927/3,118 Sec#218/265
Net Assets	$246M	US#2,590/3,118 Sec#171/265
Value
P/B	6.75x	US#2,511/3,118 Sec#181/265
P/S	593.60x	US#2,979/3,118 Sec#193/265
FCF Yield	-6.56%	US—/3,118 Sec—/265
Profitability
ROE	-49.19%	US#2,665/3,118 Sec#155/265
ROA	-45.02%	US#2,960/3,118 Sec#200/265
Op. Margin	-8411.27%	US#2,840/3,118 Sec#183/265
Revenue Growth	-62.28%	US#2,702/3,118 Sec#163/265
Financial Health
Debt Ratio	9.26%	US#96/3,118 Sec#45/265
Total Debt	$4M	US#2,911/3,118 Sec#221/265
FCF	$-109M	US#2,646/3,118 Sec#151/265
Cash	$108M	US#2,183/3,118 Sec#168/265
Current Ratio	10.63x	US#226/3,118 Sec#72/265
Performance
1Y Return	126.29%	US#46/3,118 Sec#16/265
1M Return	-12.51%	US#1,411/3,118 Sec#81/265
From 52W High	-22.77%	US#886/3,118 Sec#51/265
1Y MDD	-54.00%	US#2,540/3,118 Sec#184/265
Trading
Volume	3,491,811 shares	US#498/3,118 Sec#34/265
Trading Value	$36M	US#1,354/3,118 Sec#87/265
Per Share
EPS	$-0.71	US—/3,118 Sec—/265
BPS	$1.43	US#2,632/3,118 Sec#188/265